|
[1]
|
Sachs, G., Carlsson, E., Lindberg, P., et al. (1988) Gastric H+/K+-ATPase as therapeutic target. Annual Review of Pharmacology, 28, 269-284.
|
|
[2]
|
Scheiman, J.M. and Cutler, A.F. (1999) Helicobacter pylori and gastric cancer. The American Journal of Medicine, 106, 222-226.
|
|
[3]
|
Blum, R.A. (1996) Lansoprazole and omeprazole in the treatment of acid peptic disorders. American Journal of Health-System Pharmacy, 53, 1401-1415.
|
|
[4]
|
Andrew, F. and Lynda, W. (1996) Pantoprazole. Drugs, 51, 460-482.
|
|
[5]
|
黄东临 (2001) 2000年美国FDA批准的新药. 国外医药——合成药、生化药、制剂分册, 2, 121-122.
|
|
[6]
|
Lindberg, P., Brandstrom, A., Wallmark, B., et al. (1990) Omeprazole: The first proton pump inhibitor. Medicinal Research Reviews, 10, 1-54.
|
|
[7]
|
Lindberg, P., Nordberg, P. and Alminger, T. (1986) The mechanism of action of the gastric acid secretion inhibitor omeprazole. Journal of Medicinal Chemistry, 29, 1327-1329.
|
|
[8]
|
Shin, J.M., Cho, Y.M. and Sachs, G. (2004) Chemistry of covalent inhibition of the gastric (H+, K+)-ATPase by proton pump inhibitors. Journal of The American Chemical Society, 126, 7800-7811.
|
|
[9]
|
Matsuda, K., Yanagisawa, I., Isomura, Y., et al. (1997) One pot preparation of 1-substituted inidazole-2-thione from isothiocyanate and amino acetal. Synthetic Communications, 27, 3565-3571.
|
|
[10]
|
Pluygers, C.W. and De Vries, G. (1973) p-Chlorophenyl isothiocyanate. Organic Synthesis, 5, 223-224.
|